Cargando…

Editorial: Purinergic signaling and neuroinflammation

Detalles Bibliográficos
Autores principales:	Assmann, Charles Elias, Apolloni, Savina, Ignácio, Zuleide Maria, Bagatini, Margarete Dulce
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9798437/ https://www.ncbi.nlm.nih.gov/pubmed/36588721 http://dx.doi.org/10.3389/fphar.2022.1113063

Ejemplares similares

Therapeutic Potential of the Purinergic System in Major Depressive Disorder Associated with COVID-19
por: Simões, Júlia Leão Batista, et al.
Publicado: (2022)

Purinergic Signaling of ATP in COVID-19 Associated Guillain-Barré Syndrome
por: Simões, Júlia Leão Batista, et al.
Publicado: (2021)

Potential Therapeutic Role of Purinergic Receptors in Cardiovascular Disease Mediated by SARS-CoV-2
por: dos Anjos, Fernanda, et al.
Publicado: (2020)

COVID-19, Oxidative Stress, and Neuroinflammation in the Depression Route
por: Mingoti, Maiqueli Eduarda Dama, et al.
Publicado: (2022)

Novel possibility for cutaneous melanoma treatment by means of rosmarinic acid action on purinergic signaling
por: da Silva, Gilnei Bruno, et al.
Publicado: (2021)

Editorial: Purinergic Pharmacology
por: Ciruela, Francisco, et al.
Publicado: (2019)

Targeting purinergic receptors to suppress the cytokine storm induced by SARS-CoV-2 infection in pulmonary tissue
por: Leão Batista Simões, Júlia, et al.
Publicado: (2021)

Purinergic Signaling in Neuroinflammation
por: Aminin, Dmitry, et al.
Publicado: (2021)

Editorial: Purinergic pharmacology, Volume II
por: Ciruela, Francisco, et al.
Publicado: (2023)

Meet the Section Editor
por: Bagatini, Margarete Dulce
Publicado: (2023)

Anti-inflammatory Therapy by Cholinergic and Purinergic Modulation in Multiple Sclerosis Associated with SARS-CoV-2 Infection
por: Simões, Júlia Leão Batista, et al.
Publicado: (2021)

Editorial: Emerging Mechanisms in Purinergic Signaling: From Cell Biology to Therapeutic Perspectives
por: Gomez-Villafuertes, Rosa, et al.
Publicado: (2020)

The Impact of Purinergic System Enzymes on Noncommunicable, Neurological, and Degenerative Diseases
por: Bagatini, Margarete Dulce, et al.
Publicado: (2018)

Purinergic Signalling: Therapeutic Developments
por: Burnstock, Geoffrey
Publicado: (2017)

Signaling of the Purinergic System in the Joint
por: Corciulo, Carmen, et al.
Publicado: (2020)

Editorial: “Purinergic Signaling 2020: The State-of-The-Art Commented by the Members of the Italian Purine Club”
por: Ciruela, Francisco, et al.
Publicado: (2021)

The Impact of Stress from Social Isolation during the COVID-19 Pandemic on Psychiatric Disorders: An Analysis from the Scientific Literature
por: Bertollo, Amanda Gollo, et al.
Publicado: (2023)

Purinergic Signaling in Mast Cell Degranulation and Asthma
por: Gao, Zhan-Guo, et al.
Publicado: (2017)

Neuroinflammation in Friedreich’s Ataxia
por: Apolloni, Savina, et al.
Publicado: (2022)

Targeting Purinergic Signaling in the Dynamics of Disease Progression in Sepsis
por: Leite-Aguiar, Raíssa, et al.
Publicado: (2021)

Aluminum-Induced Alterations in Purinergic System Parameters of BV-2 Brain Microglial Cells
por: Assmann, Charles Elias, et al.
Publicado: (2021)

Deregulation of purinergic ectoenzyme activity in head and neck cancer promotes immunosuppression
por: Marafon, Filomena, et al.
Publicado: (2022)

Editorial: Purinergic Signaling and Inflammation
por: Yuan, Xiaoyi, et al.
Publicado: (2021)

Therapeutic Potential of Astrocyte Purinergic Signalling in Epilepsy and Multiple Sclerosis
por: Nobili, Paola, et al.
Publicado: (2022)

Nanobody-Based Biologics for Modulating Purinergic Signaling in Inflammation and Immunity
por: Menzel, Stephan, et al.
Publicado: (2018)

Metabolic Changes Induced by Purinergic Signaling: Role in Food Intake
por: Caruso, Vanni, et al.
Publicado: (2021)

Purinergic signaling: A gatekeeper of blood-brain barrier permeation
por: Wang, Yuemei, et al.
Publicado: (2023)

Diabetes and hypertension: Pivotal involvement of purinergic signaling
por: Reichert, Karine Paula, et al.
Publicado: (2021)

Editorial: Purinergic Signaling in Health and Disease
por: Boué-Grabot, Eric, et al.
Publicado: (2020)

Use of Humanized Mouse Models to Investigate the Roles of Purinergic Signaling in Inflammation and Immunity
por: Sluyter, Ronald, et al.
Publicado: (2020)

Editorial: The Role of Neuroinflammation in Chronic Pain Development and Maintenance
por: De Logu, Francesco, et al.
Publicado: (2021)

Editorial: Pharmacological approaches towards the resolution of neuroinflammation and neurodegeneration
por: Liang, Huazheng, et al.
Publicado: (2023)

Post-inflammatory Ileitis Induces Non-neuronal Purinergic Signaling Adjustments of Cholinergic Neurotransmission in the Myenteric Plexus
por: Vieira, Cátia, et al.
Publicado: (2017)

Elevated Pressure Changes the Purinergic System of Microglial Cells
por: Rodrigues-Neves, Ana C., et al.
Publicado: (2018)

Erythrocytes Induce Endothelial Injury in Type 2 Diabetes Through Alteration of Vascular Purinergic Signaling
por: Mahdi, Ali, et al.
Publicado: (2020)

Purinergic Receptors in Neurological Diseases With Motor Symptoms: Targets for Therapy
por: Oliveira-Giacomelli, Ágatha, et al.
Publicado: (2018)

Biology of Platelet Purinergic Receptors and Implications for Platelet Heterogeneity
por: Koupenova, Milka, et al.
Publicado: (2018)

The Guanine-Based Purinergic System: The Tale of An Orphan Neuromodulation
por: Di Liberto, Valentina, et al.
Publicado: (2016)

Purinergic P2 Receptors: Novel Mediators of Mechanotransduction
por: Kong, Qihang, et al.
Publicado: (2021)

Editorial: Neuroinflammation and Its Resolution: From Molecular Mechanisms to Therapeutic Perspectives
por: Zusso, Morena, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ucvvcq5vmk3k60tvj613jmgv7f